The legacy of Viagra and its impact on the pharmaceutical landscape presents a intriguing question for shareholders . Initially a blockbuster drug, generics have significantly chipped away at its market dominance, creating obstacles for companies connected to the original patent holder and related developments . While certain companies might gain f